Allurion Technologies Inc. (ALUR)

USD 2.54

(-8.63%)

Long Term Debt Summary of Allurion Technologies Inc.

  • Allurion Technologies Inc.'s latest annual long term debt in 2023 was 2.3 Million USD , down -56.21% from previous year.
  • Allurion Technologies Inc.'s latest quarterly long term debt in 2024 Q2 was 40.95 Million USD , down 0.0% from previous quarter.
  • Allurion Technologies Inc. reported annual long term debt of 5.26 Million USD in 2022, up 162.91% from previous year.
  • Allurion Technologies Inc. reported annual long term debt of 2 Million USD in 2021, down 0.0% from previous year.
  • Allurion Technologies Inc. reported quarterly long term debt of 40.95 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Allurion Technologies Inc. reported quarterly long term debt of 2.51 Million USD for 2023 Q3, down -88.88% from previous quarter.

Annual Long Term Debt Chart of Allurion Technologies Inc. (2023 - 2020)

Historical Annual Long Term Debt of Allurion Technologies Inc. (2023 - 2020)

Year Long Term Debt Long Term Debt Growth
2023 2.3 Million USD -56.21%
2022 5.26 Million USD 162.91%
2021 2 Million USD 0.0%
2020 - USD 0.0%

Peer Long Term Debt Comparison of Allurion Technologies Inc.

Name Long Term Debt Long Term Debt Difference
Abbott Laboratories 13.59 Billion USD 99.983%
Artivion, Inc. 305.53 Million USD 99.245%
Avanos Medical, Inc. 159.4 Million USD 98.553%
Butterfly Network, Inc. 22.83 Million USD 89.901%
Butterfly Network, Inc. 22.83 Million USD 89.901%
Bio-Rad Laboratories, Inc. 1.18 Billion USD 99.806%
Boston Scientific Corporation 8.96 Billion USD 99.974%
CONMED Corporation 971.48 Million USD 99.763%
Edwards Lifesciences Corporation 670 Million USD 99.656%
Paragon 28, Inc. 109.79 Million USD 97.9%
Glaukos Corporation 383.73 Million USD 99.399%
Globus Medical, Inc. 417.4 Million USD 99.448%
Inspire Medical Systems, Inc. 24.84 Million USD 90.719%
Integer Holdings Corporation 959.92 Million USD 99.76%
Medtronic plc 23.87 Billion USD 99.99%
Myomo, Inc. 115.16 Thousand USD -1902.431%
Nevro Corp. 211.47 Million USD 98.91%
Owlet, Inc. 22 Thousand USD -10381.818%
Penumbra, Inc. 220.9 Million USD 98.956%
Vicarious Surgical Inc. 13.78 Million USD 83.272%
Smith & Nephew plc 2.17 Billion USD 99.894%
Sonendo, Inc. 14.03 Million USD 83.57%
STERIS plc 3.12 Billion USD 99.926%
Stryker Corporation 10.9 Billion USD 99.979%
Vapotherm, Inc. 109.97 Million USD 97.903%
Zimmer Biomet Holdings, Inc. 4.86 Billion USD 99.953%